PKR 抑制剂通过减轻内分泌网膜应激和热致死来保护脊髓损伤
Ze Yang1, Ming Sheng2, Meng Wang1
1Spine Minimally Invasive Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524001, China.
Neurochemistry international
|October 22, 2023
概括
抑制蛋白激酶R (PKR) 减少脊髓损伤 (SCI) 的损伤,并改善功能恢复. 这种方法调节了微质灭和内质网膜应激,为SCI提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 脊髓损伤 (SCI) 是一种毁灭性的神经系统疾病.
- 目前尚不完全理解SCI病原性背后的精确调节机制.
- 蛋白激酶R (PKR) 已成为神经损伤的潜在参与者.
研究的目的:
- 研究蛋白激酶R (PKR) 在脊髓损伤 (SCI) 中的调节作用.
- 阐明PKR参与SCI的潜在分子机制.
- 在SCI模型中评估PKR抑制的治疗潜力.
主要方法:
- 利用已建立的SCI动物和细胞模型.
- 在SCI模型中使用PKR抑制剂C16.
- 评估了组织学损伤,细胞亡,功能恢复 (BBB分数,握力),氧化应激和细胞因子产生.
- 通过西方斑点和免疫光检查了蛋白质表达.
- 通过共免疫沉研究PKR-STAT1相互作用.
主要成果:
- 在SCI后,PKR表达增加.
- 抑制PKR (C16) 缓解了SCI诱导的组织损伤,亡,并改善了功能恢复.
- 在SCI模型和LPS挑战的BV-2细胞中,C16治疗减轻了ER压力,热,NLRP3炎症酶激活和炎症.
- PKR与STAT1相互作用,而STAT1的敲击抑制了ER的压力,热和炎症.
结论:
- 抑制PKR是一种有前途的治疗策略,可以减轻SCI.
- 通过PKR抑制调节微质烧和ER压力,可以加速SCI后的功能恢复.
- 准PKR-STAT1通路为SCI治疗提供了一个潜在的机制.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K


